Evaluation of Kaletra Therapy Over the Long-term

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Long term observation of patients under lopinavir/ritonavir containing therapy

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abbott
• Treatments: Lopinavir; Ritonavir

Criteria

Inclusion Criteria:

• Patients infected by HIV-1

• Age greater than or equal to 18 years

Exclusion Criteria:

• as described in SmPC (summary of product characteristics) at the time of prescription